“The Characteristics of Cardiovascular Adverse Events in Therapy With Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team”. Voprosy onkologii 70, no. 3 (July 4, 2024): 541–549. Accessed October 14, 2026. http://voprosyonkologii.ru/index.php/journal/article/view/3-24-The-Characteristics.